Motorica, a leading global MedTech innovator in assistive technologies and medical cybernetics, has introduced the Omni Hand, the world’s first bionic hand prosthesis powered by optical myography (OMG) sensors. This pioneering advancement redefines how humans interact with prosthetic technology, marking a milestone in intuitive, mind-driven movement control.
Unlike conventional prosthetics that rely on electrical muscle signals, the Omni Hand uses optical sensors to detect minute shifts in light within tissues, generated by muscle and tendon movements. These light-based readings are instantly analyzed and converted into precise, natural motions. The result is a highly responsive prosthesis that allows smoother, more instinctive control — even for users with limited muscle function due to injuries or trauma.
“Omni Hand is more than a device — it’s an intelligent extension of the human body,” said Andrei Davidiuk, CEO of Motorica. “It perceives intent rather than just motion, allowing users to perform actions as naturally as they imagine them. This technology brings us closer to the seamless fusion of biology and robotics.”
The prosthesis can interpret and reproduce up to six distinct “phantom gestures” — movements imagined by the brain, such as gripping, pinching, or pointing — without requiring manual mode switching. Its adaptive algorithm continuously learns from user behavior through an embedded decision-support system, refining control accuracy with each use. Over time, the Omni Hand evolves alongside its wearer, personalizing performance for maximum comfort and precision.
Motorica has become the first company globally to commercialize optical sensing technology in prosthetics, moving it from laboratory research to real-world application. A pilot program with the first eight users has already shown promising results, and mass production is scheduled for 2026, with plans to make the technology widely available to users around the world.
Founded in 2015, Motorica ranks among the top ten companies in the global upper-limb prosthetics market. The company designs and manufactures advanced upper and lower limb prostheses for adults and children as young as two years old. To date, Motorica has produced more than 9,000 prosthetic devices for users across 17 countries, including India, Vietnam, and nations across the Middle East and Russia.
Motorica established its first Indian office in 2025 and now collaborates with over 25 clinics nationwide, covering key regions such as Delhi NCR, Maharashtra, Karnataka, Uttar Pradesh, and Tamil Nadu. Its prosthetics combine 3D printing, robotics, microelectronics, precision metalworking, and laser sintering, with options for custom designs and realistic skin-tone finishes that closely replicate the appearance of a natural limb.
The company has been recognized with the 2024 BRICS Solutions Award in Biotechnology and National Health Care and continues to lead in research focused on restoring sensory feedback and reducing phantom pain through neural stimulation. Early testing of this sensory technology allows users to distinguish between hard and soft objects and even perceive size and texture. In 2024, Motorica expanded its product line to include carbon foot prostheses, developed in partnership with IB-ER (Turkey), responding to rising global demand for advanced lower-limb solutions.
